FEBBO WILLIAM J — SEC Form 4 filings
SEC reporting owner CIK 1413987. 10 Form 4 filings on record with FilingPulse; latest filed 2026-06-26.
Transaction summary — filings shown
Covers all 10 filings on record, filed 2024-01-18 to 2026-06-26. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing — 20,000 shares, $100,220 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 15.
- Largest priced transaction: purchase of 20,000 shares @ $5.01 ($100,220) in OptimizeRx Corp, filed 2024-12-16.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| OptimizeRx Corp (OPRX) | CEO, Director | 6 | 1 leg · 20,000 sh · $100,220 | — | 9 |
| Augmedix, Inc. (AUGX) | Director | 2 | — | — | 4 |
| MYOMO, INC. (MYO) | Director | 2 | — | — | 2 |
Form 4 filings — FEBBO WILLIAM J
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-26 | 4 | MYOMO, INC. (MYO) | Grant/award (A): 78,704 @ $0 | EDGAR |
| 2026-04-16 | 4 | MYOMO, INC. (MYO) | Grant/award (A): 45,000 @ $0 | EDGAR |
| 2025-02-20 | 4 | OptimizeRx Corp (OPRX) | Tax withholding (F): 401 @ $6.64 | EDGAR |
| 2024-12-16 | 4 | OptimizeRx Corp (OPRX) | Purchase (P): 20,000 @ $5.01 | EDGAR |
| 2024-10-04 | 4 | Augmedix, Inc. (AUGX) | Disposition to issuer (D): 162,583 @ $2.35 · Disposition to issuer (D): 50,000 (derivative) @ $0 | EDGAR |
| 2024-07-15 | 4 | Augmedix, Inc. (AUGX) | Option exercise (M): 21,598 · Option exercise (M): 21,598 (derivative) @ $0 | EDGAR |
| 2024-06-12 | 4 | OptimizeRx Corp (OPRX) | Option exercise (M): 28,895 @ $0 · Tax withholding (F): 782 @ $9.35 · Option exercise (M): 28,895 (derivative) @ $0 | EDGAR |
| 2024-04-24 | 4 | OptimizeRx Corp (OPRX) | Grant/award (A): 15,000 @ $0 | EDGAR |
| 2024-04-17 | 4 | OptimizeRx Corp (OPRX) | Grant/award (A): 60,000 @ $0 | EDGAR |
| 2024-01-18 | 4 | OptimizeRx Corp (OPRX) | Option exercise (M): 9,628 @ $0 · Tax withholding (F): 2,884 @ $13.25 · Option exercise (M): 9,628 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1413987 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →